258 related articles for article (PubMed ID: 10956646)
1. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.
Wu Y; Bressette D; Carrell JA; Kaufman T; Feng P; Taylor K; Gan Y; Cho YH; Garcia AD; Gollatz E; Dimke D; LaFleur D; Migone TS; Nardelli B; Wei P; Ruben SM; Ullrich SJ; Olsen HS; Kanakaraj P; Moore PA; Baker KP
J Biol Chem; 2000 Nov; 275(45):35478-85. PubMed ID: 10956646
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.
Marsters SA; Yan M; Pitti RM; Haas PE; Dixit VM; Ashkenazi A
Curr Biol; 2000 Jun; 10(13):785-8. PubMed ID: 10898980
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
[TBL] [Abstract][Full Text] [Related]
4. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
6. BLyS and APRIL in rheumatoid arthritis.
Seyler TM; Park YW; Takemura S; Bram RJ; Kurtin PJ; Goronzy JJ; Weyand CM
J Clin Invest; 2005 Nov; 115(11):3083-92. PubMed ID: 16239971
[TBL] [Abstract][Full Text] [Related]
7. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
8. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
10. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
[TBL] [Abstract][Full Text] [Related]
11. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
[TBL] [Abstract][Full Text] [Related]
12. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
[TBL] [Abstract][Full Text] [Related]
13. Discovery of high-affinity peptide binders to BLyS by phage display.
Fleming TJ; Sachdeva M; Delic M; Beltzer J; Wescott CR; Devlin M; Lander RC; Nixon AE; Roschke V; Hilbert DM; Sexton DJ
J Mol Recognit; 2005; 18(1):94-102. PubMed ID: 15382264
[TBL] [Abstract][Full Text] [Related]
14. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.
Xia XZ; Treanor J; Senaldi G; Khare SD; Boone T; Kelley M; Theill LE; Colombero A; Solovyev I; Lee F; McCabe S; Elliott R; Miner K; Hawkins N; Guo J; Stolina M; Yu G; Wang J; Delaney J; Meng SY; Boyle WJ; Hsu H
J Exp Med; 2000 Jul; 192(1):137-43. PubMed ID: 10880535
[TBL] [Abstract][Full Text] [Related]
15. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
Diaz-de-Durana Y; Mantchev GT; Bram RJ; Franco A
Blood; 2006 Jan; 107(2):594-601. PubMed ID: 16195331
[TBL] [Abstract][Full Text] [Related]
16. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
17. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
[TBL] [Abstract][Full Text] [Related]
18. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.
Roschke V; Sosnovtseva S; Ward CD; Hong JS; Smith R; Albert V; Stohl W; Baker KP; Ullrich S; Nardelli B; Hilbert DM; Migone TS
J Immunol; 2002 Oct; 169(8):4314-21. PubMed ID: 12370363
[TBL] [Abstract][Full Text] [Related]
19. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
20. Immunology. Lymphocyte survival--ignorance is BLys.
Laâbi Y; Strasser A
Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
